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Background 
On average, more than 50,000 refugees relocate to the United States annually. 1 They come from 
diverse regions of the world and bring with them health risks and diseases common to all refugee 
populations as well as some that may be unique to specific populations. The purpose of this 
document is to describe general and optional testing components that do not fall into the specific 
disease categories of these guidelines. These guidelines are based upon principles of best 
practices, with references to primary published reports when available. 
This document differs from others in the guidelines, which recommend screening for specific 
disorders. The guidelines in this document include testing for abnormalities or clinical conditions 
that are not specific disorders but are suggestive of underlying disorders. The tests in this 
document may indicate either acute or chronic disorders and generally indicate the need for 
further testing and evaluation to identify the condition causing the abnormality. Testing for 
chronic health conditions is important, since these conditions are common in newly arriving 
refugees, both children and adults. 2 Since refugee populations are diverse and are predisposed to 
diseases that may differ from those found in the U.S. population, the differential diagnosis and 
initial evaluation of abnormalities are discussed to assist the clinician. 
 
General and Optional Tests 
Many disorders may be detected by using general, nonspecific testing modalities. Preventive 
screening, counseling, and testing, which are routinely used in the general U.S. population, may 
identify people with or at risk for chronic disorders. In addition, the process of migration and 
adaptation to a new lifestyle in the United States generally predisposes refugees to disorders, 
such as hyperlipidemia and cardiovascular diseases, not commonly encountered in refugee 
populations on arrival. This document discusses guidelines (Table 1) for conditions commonly 
detected on arrival, including hematologic disorders, renal disease, and metabolic disorders of 
adults and children. In addition, medical screening routinely recommended in the United States 
for such conditions as cardiovascular diseases and cancers should be performed. This may be 
done at the new-arrival medical evaluation, or arrangements should be made for timely follow-up 
with primary care for testing. 
 
Table 1. General and Optional Testing for Newly Arrived Refugees  
Recommended for All Refugees 
 Complete blood count with a white blood cell differential 
and platelets  
 Urinalysis (if old enough to provide a clean-catch urine 
specimen)  
 Infant metabolic screening in newborn infants, according to 
state guidelines  
Recommended for Specific 
Populations 
 Serum lipid profile a  
 Cancer screening b  
 Uric acid (for Hmong refugees)  
Optional  Serum chemistries and glucose  
• a See Discussion and Table 4 for population-specific information.  
• b See Discussion and Table 5 for population-specific information.  
Discussion 
1. Complete Blood Count with Red Blood Cell Indices, White Blood Cell 
Differential, and Platelet Count 
Who Should Be Tested 
Newly arrived refugees of all ages and ethnicities 
Potential Disorders Detected 
A. Anemia 
Anemia is a common finding in refugees of all ages and ethnicities. The prevalence of anemia in 
selected groups of newly arrived populations has ranged from 19% among African refugees 
resettling in Australia to 37% among Southeast Asian refugees resettling in the United States. 2 3 
Anemia was identified in 12% of 1,247 refugee children in Massachusetts, with a rate of 29% 
among children under 2 years. 4 In addition, a study in Maine found 20% of 127 refugee children 
were anemic at the time of their new-arrival medical evalution. 5 
Anemia may result from a wide range of disease processes. Common causes of anemia in 
refugee populations include iron deficiency, inherited hematologic abnormalities (e.g., 
thalassemias, hemoglobinopathies, enzyme defects), and infectious diseases (e.g., malaria, 
intestinal parasitosis). The ultimate cause is often multifactorial;6 therefore, the clinician needs to 
consider multiple conditions whenever anemia is detected. The complete evaluation of anemia in 
refugees is beyond this scope of this document, but common causes and initial testing are 
discussed below and summarized in Table 2. 
Iron-Deficiency Anemia (IDA) 
IDA, probably the most common cause of anemia in immigrant populations, is usually 
manifested as a microcytic anemia (Table 2). The groups most commonly affected are children 
and women;7 however, refugees of both sexes and all age groups are at risk. Although IDA is 
frequently multifactorial, it is primarily caused by deficient dietary iron. Chronic blood loss, 
which frequently adds to iron deficiency, is commonly caused by infection with intestinal 
parasites, particularly hookworm. Helicobacter pylori infections may lead to gastrointestinal 
blood loss through ulcer formation. If iron deficiency has not been longstanding or severe, frank 
anemia may not result, but changes in red blood cell morphology, including microcytosis (low 
mean corpuscular volume) and increased red cell distribution width (RDW), may be noted. In a 
convenience sample of newly arrived western, central, and eastern African refugees to Australia, 
20% had ferritin levels that indicated iron deficiency. 2 Studies in the United States have also 
shown a high prevalence of iron deficiency in Southeast Asian refugees. 8 
Iron deficiency likely increases intestinal absorption of lead. 9 To address the high prevalence of 
iron deficiency in refugee children and decrease their likelihood of developing elevated lead 
levels after arrival to the United States, CDC recommends that all children aged 6 months to 16 
years have a lead level test and all children aged 6 to 59 months receive pediatric multivitamins 
after arrival (see Lead Section for more details). 
Inherited Anemias 
Inherited hematologic disorders are common among many refugee populations and should be 
considered in any refugee who has anemia detected on screening, even if other potential causes 
exist (e.g., iron deficiency, particularly if not corrected with therapy). These disorders include 
thalassemias, hemoglobinopathies, enzyme defects, and cell membrane defects. These conditions 
are most common in malaria-endemic regions, since they may provide some defense against this 
infection. Most of these conditions are autosomal recessive (except for glucose-6-phosphate 
dehydrogenase deficiency, which is an X-linked disorder). Therefore, it is important to both 
identify symptomatic refugees who are homozygous for an abnormal gene and to detect 
heterozygous carriers, since their offspring may be affected by the disease (Table 2). 
Thalassemias are a group of disorders characterized by a decrease in either the alpha or beta 
globin chain production in red blood cells (RBCs). Globally, most people with thalassemia are 
born in or are descended from populations in eastern Asia, the Philippines, Indonesia, India, 
Pakistan and the Middle East. 9 10 A large increase in the prevalence of all forms of thalassemia 
has been reported in North America, mostly as a result of immigration from Asian and Middle-
Eastern groups in recent decades. 10 In California, the rate of hemoglobin H disease (or α-
thalassemia) in newborns is high for several Asian immigrant populations: 1/2,500 in Chinese 
and Vietnamese, 1/1,400 in Filipino, 1/800 in Cambodian, and 1/160 in Laotian newborns. 10 
Four conditions make up the α-thalassemias, defined by the number of inherited deletions of the 
four alpha globin genes. 10 If only one deleted gene is inherited, the person is a silent carrier. 
Alpha-thalassemia trait occurs when two deleted genes are inherited (either [a_/a_] or [aa/__). 
Affected people are asymptomatic but usually have a mild microcytic anemia. This condition is 
important to identify, as the red cell indices resemble IDA; however, administration of iron in 
alpha-thalassemia trait may be harmful to the patient. When three deleted alpha globin genes are 
inherited, the result is α-thalassemia (hemoglobin H disease). Affected people have microcytic 
hypochromic anemia at birth and may have aplastic or hemolytic crises throughout life as a result 
of viral infections. Hemoglobin H disease may present with complications of gallstone formation 
or physical exam findings of splenomegaly or growth failure. 8 Roughly half of people with 
hemoglobin H disease have inherited two deleted alpha globin genes, in combination with a 
nondeletional mutation called the "constant spring mutation." These people may have a more 
severe clinical course than those with the classic three-deletion hemoglobin H disease. 8 If a fetus 
inherits four deleted alpha globin genes, hemoglobin Bart’s disease results. Typically, these 
fetuses do not survive. 8 
People who have inherited one deleted beta globin gene have β-thalassemia minor (trait). These 
people have mild microcytic anemia but have no symptoms related to the condition. People who 
have inherited two deleted beta globin genes have β-thalassemia major. Typically symptoms 
manifest at 8 to 10 months of life, after fetal hemoglobin production has stopped. These patients 
have severe anemia and fatigue. They may have frontal cranial bossing, other bony changes, and 
liver and spleen enlargement as a result of extramedullary hematopoesis. Affected people may be 
jaundiced and are at increased risk of gallstone formation. This condition typically requires 
frequent blood transfusions and iron chelation. 8 
The hemoglobinopathies are conditions characterized by production of abnormal globin chains. 
Perhaps the most widely known of these conditions is sickle cell disease, due to replacement of 
glutamic acid by a valine at the sixth amino acid position of the beta chain. Globally, 80% of 
people affected by sickle cell disease live in or have origins in central Africa. The condition also 
affects people from Central and South America, the Arabian Peninsula, Middle East, India, and 
eastern Mediterranean. 11 
Hemoglobin E trait, caused by substitution of a lysine by a glutamic acid at position 26 of the 
beta chain, is another hemoglobinopathy that is frequently present in certain refugee groups, 
particularly from Southeast Asia. Both heterozygotes and homozygotes are asymptomatic but 
have hypochromic microcytosis and mild anemia. 12 However, in people who are carriers of both 
the hemoglobin E gene and the beta-thalassemia gene deletion, severe anemia may result. The 
prevalence of hemoglobin E is very high in areas of Southeast Asia – nearly 60% in regions of 
Thailand, Laos, and Cambodia. 10 In California, 25% of Cambodian newborns and just over 10% 
of Thai and Laotian newborns are hemoglobin E carriers. 10 Hemoglobin E is also seen in many 
people from Indonesia, Bangladesh, northeast India, Sri Lanka, and parts of the Middle East. 8 12 
As with the thalassemias, hemoglobin E red cell indices are similar to IDA; however, unless the 
patient is also iron deficient, administration of iron will not improve the condition and may be 
harmful. 
Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme present in red blood cells. G6PD 
deficiency is the most common inherited enzyme deficiency, affecting over 400 million people 
globally. In certain circumstances it may cause acute hemolytic anemia. The geographic 
distribution of this condition matches that of the thalassemias listed above, but the condition is 
particularly common in Southeast Asia. 11 The enzymatic function of G6PD helps recycle 
glutathione inside RBCs. Glutathione is important for preventing oxidative damage to RBCs, 
which can occur when hemoglobin interacts with oxidizing agents. RBCs become rigid, resulting 
in their hemolytic destruction in the spleen and other reticuloendothelial organs. Intravascular 
hemolysis may also occur. Since the gene that codes for G6PD is located on the X chromosome, 
men are typically more severely affected than women. Most people with G6PD deficiency are 
asymptomatic until exposed to oxidizing medications. Examples of particular concern for 
refugee populations include sulfas, primaquine for malaria, and dapsone, which is commonly 
used for leprosy and as a prophylactic agent in HIV-infected people. Laboratory findings during 
an acute hemolytic event include normocytic anemia, increased reticulocyte count, normal liver 
enzymes, and an elevated indirect bilirubin. A urinalysis may be heme positive without RBCs on 
microscopic examination. 8 
To prevent an acute hemolytic episode, any refugee from a high-risk area should be tested for 
G6PD activity before oxidizing medications are prescribed. In addition, the new-arrival medical 
exam should include historical questions to identify past episodes of hemolysis, including 
prolonged or unusually severe neonatal jaundice, recurrent episodes of anemia, hemoglobinuria, 
jaundice, or gallstones. If the patient comes from a high-prevalence area, a positive history for 
any of these conditions warrants testing for G6PD deficiency prior to use of any oxidizing 
agents. 8 
B. Eosinophilia 
Eosinophilia may be defined as an eosinophil percentage exceeding 5% or an absolute eosinophil 
count (AEC) exceeding 400 eosinophils/mm3 (some authors use AEC of >500 mm3). The AEC is 
generally a better reference, as frequently a patient will have a normal eosinophil percentage 
when the AEC is elevated, indicating an infection or other condition. If laboratory reports do not 
include the AEC, it can calculated by multiplying the total white blood count by the eosinophil 
percentages. 
Eosinophilia in a newly arrived refugee most likely indicates the presence of a parasitic infection 
(see Presumptive Treatment and Medical Screening for Parasites in Newly Arriving Refugees), 
although other etiologies such as allergies, medication reactions, and atopy, may account for the 
finding (Table 2). 
C. Thrombocytopenia 
A variety of conditions may cause thrombocytopenia, including many infectious diseases, 
although a discussion of the complete differential diagnosis and evaluation of thrombocytopenia 
is beyond this text. However, some conditions rare in the general U.S. population may be 
common in certain groups of refugees and are noted here. These include any tropical infection 
that may cause hypersplenism (especially schistosomiasis, visceral leishmaniasis and malaria, or 
more rarely, brucellosis). In addition, certain infections that may not elicit clinical symptoms 
during the examination may cause thrombocytopenia through other mechanisms, such as HIV 
infection (up to 40% of infected people will have low platelet counts) or acute infection with 
malaria in a semi-immune person. 8 
D. Other Conditions 
A CBC with differential may reveal clues to a wide range of other, less common disorders such 
as malignancy (e.g., leukemia), vitamin deficiencies indicated by megaloblastic anemia (e.g., 
B12, folate), anemia of chronic disease, and endocrinopathies (e.g. thyroid disease) (Table 2). 
Initial evaluation of anemia and follow-up testing: 
If anemia is present, the cause should be sought (Table 2). The large number of differential 
diagnoses and often multifactorial causes mean that an anemia cannot be assumed to be due to 
common iron deficiency. 6 All patients with a microcytotic anemia should have iron studies 
checked. If iron deficiency is not present or is unresponsive to therapy, hemoglobin 
electrophoresis should be performed to identify thalassemias and hemoglobinopathies. Alpha-
thalassemia trait cannot be diagnosed by hemoglobin electrophoresis beyond the newborn age; it 
can only be inferred as the cause of iron-nonresponsive microcytic anemia in a person with a 
normal hemoglobin electrophoresis and no other identifiable source of microcytic anemia. 8 
Additional tests to consider include blood lead levels for any person with anemia or microcytosis 
(although blood lead testing is routinely recommended in children 6 months to 16 years; see 
Lead Section). In addition, given the very high infection rates, H. pylori, which results in peptic 
ulcer disease, should be considered in people with microcytic anemias, especially among those 
who do not respond well to iron replacement or who have abdominal complaints. 13 
If eosinophilia is detected, the necessary follow-up testing depends on the type of pre-departure 
parasite treatment the refugee received (See Presumptive Treatment and Medical Screening for 
Parasites in Newly Arriving Refugees). 
The evaluation of thrombocytopenia may be extensive. Any refugee from a malaria-endemic 
country should be tested for malaria as an initial step. Initial or repeat testing for HIV should be 
considered. When thrombocytopenia and splenomegaly are present, the patient should be 
referred to a specialist for evaluation for infections (e.g., schistosomiasis, leishmaniasis, and 
malaria), as well as other possible causes, such as malignancy. 
After a careful history and physical examination, most clinicians will begin evaluation with a 
peripheral blood smear for morphology. An initial differential diagnosis may be generated by 
using the red blood cell indices. 
Table 2. Common causes of anemia in refugees and recommended initial testing 
Anemia Common Causes in Refugees Frequent Initial Laboratory Investigations 
Microcytic 
anemia c 
• Iron-deficiency anemia d  
• Thalassemias and 
hemoglobinopathies  
• Iron studies (serum iron, total 
iron binding capacity, iron 
saturation, ferritin)  
• Reticulocyte count  
• Hemoglobin electrophoresis e  
• Lead level f  
Normocytic 
anemia c 
Chronic diseases  
• Hepatic or renal disease  
• Neoplasms  
• Collagen vascular disease  
• Infections  
o Protozoal (e.g., malaria, 
leishmaniasis)  
o Bacterial (e.g., 
tuberculosis)  
o Viral (e.g., hepatitis, 
mononucleosis)  
History-directed  
• Reticulocyte count  
Macrocytic 
anemia c 
• Vitamin B-12 deficiency  
• Folate deficiency  
• Medications  
• Alcohol  
• Thyroid disease  
• Liver disease  
• HIV infection  
• Serum B12 and folate levels  
• Red blood cell folate level  
• Thyroid function tests  
• Reticulocyte count  
• c Commonly multifactorial in refugees. If high, RDW may have mixed microcytic, 
normocytic or macrocytic causes.  
• d Many causes, including nutritional, direct blood loss (e.g., menses, ulcer disease, 
carcinoma, hookworm infection), chronic disease.  
• e If no iron deficiency or if iron-deficiency anemia is not completely corrected with iron 
therapy.  
• f Particularly important in children. Not a cause of anemia, but rather a consequence of 
iron deficiency.  
Note: G6PD does not cause anemia unless oxidative stress induces hemolytic anemia. It should 
be checked, particularly in Southeast Asian populations, before medications are prescribed with 
oxidizing potential (e.g., sulfa agents, primaquine). 
 
2. Urinalysis 
Who Should Be Tested 
There is no evidence that routine urinalysis is a cost-effective screening examination. It may be 
considered in newly arrived refugees of all ages and ethnicities who are developmentally mature 
enough to provide a clean-catch urine specimen. A bag specimen may be checked for younger 
children, if clinically indicated, with confirmation of positive findings by catheterization. 5 This 
recommendation is more conservative than the current American Academy of Pediatric 
guidelines for children residing in the United States, because of the higher prevalences of 
specific conditions that may be detected in refugee children (e.g., Schistosoma haematobium). 
Potential Disorders Detected 
A. Schistosoma haematobium 
Schistosoma haematobium is parasite present in Africa and the Middle East. In some populations 
(e.g., people living in endemic areas of Nigeria and Ghana), infection rates may exceed 90%. 15 
16 17 Infection presents with intermittent microcytic or gross hematuria, which may be 
accompanied by dysuria or increased frequency. Infection is highly associated with squamous 
cell carcinoma of the bladder. 6 Although the infection is frequently accompanied by an AEC, 
confirmation is made by schistosomiasis serologic tests and/or urine ova and parasite 
examination. Schistosomiasis in refugees is discussed further in the intestinal parasites guidelines 
(www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/intestinal-parasites-domestic.html) 
B. Renal Diseases 
Although not a primary reason for a screening urinalysis, clues to the presence of many different 
types of systemic and renal disease may be incidentally revealed, and abnormal results should be 
investigated. 
C. Systemic Diseases 
A positive dipstick for glucose is suggestive of diabetes. Although no evidence supports formal 
screening of nonimmigrant adults for diabetes by fasting glucose measurements, refugee 
populations have never been studied. Newly arriving refugees constitute a medically vulnerable 
population in which realities such as lack of awareness, difficulties of navigating complicated 
health-care systems, and sporadic medical insurance coverage may sway the balance in favor of 
screening for asymptomatic diabetes. Although urinalysis is inferior to fasting blood glucose, the 
presence of glucosuria is suggestive of diabetes. 
D. Sexually Transmitted Infections (STIs) 
A urinalysis can give clues to the presence of sexually transmitted infections. A positive dipstick 
for leukocyte esterase or increased numbers of white blood cells in the microscopic exam is 
suggestive of chlamydia or gonoccocal infection. However, because of its low sensitivity this test 
should not be considered an effective screening method for these infections. For example, in one 
study, the presence of leukocyte esterase was only 61% sensitive for chlamydia infections in 
males. 14 For a complete discussion of screening refugees for STIs, see Screening for Sexually 
Transmitted Infections. 
 
3. Chemistries 
No evidence supports universal screening of asymptomatic refugees for electrolyte and other 
chemistry abnormalities. However, a basic panel including blood urea nitrogen and creatinine 
should be considered if indicated by signs, symptoms, or comorbidities. A basic panel may also 
be considered in certain groups with high rates of chronic renal disease, such as the Hmong. In 
addition, uric acid in Hmong refugees may be considered, since the prevalence of hyperuricemia 
and related diseases such as gout and end-stage renal disease is high in this population. 
 
4. Newborn Screening 
There is no evidence that newborn screening is beneficial in refugee infants or children. 
However, if a newborn refugee infant is seen for refugee medical screening, a newborn screening 
panel, as dictated by the respective state, should be performed. 
 
5. Cardiovascular and Lipid Disorder Screening 
Refugees should be screened for cardiovascular and lipid disorders in accordance with the US 
Preventive Services Task Force (USPSTF) guidelines (Table 3). 18 Although blood pressure and 
nonfasting serum lipid testing can be performed at the new-arrival medical screening 
examination, other screening tests recommended by the USPSTF may not be conducted at this 
visit but should be done in a reasonable time frame after arrival. Adults found to have 
hyperlipidemia or hypertension should be formally screened for diabetes with a fasting blood 
glucose measurement, in accordance with USPSTF guidelines, and should be referred for long-
term management. 
Table 3. U.S. Preventive Services Task Force Guidelines for routine medical screening for lipid 
disorders, hypertension, and abdominal aortic aneurysm.  
Lipid disorders 
 Screen and treat men ≥35 years and women ≥45 years of age for lipid 
disorders by obtaining, at the minimum, total cholesterol and high-density 
lipoprotein levels. These can be checked in a nonfasting state.  
 Screen and treat men 20-35 years and women 20-45 years of age if they have 
increased risk for coronary heart disease (diabetes, tobacco use, hypertension, 
family history of cardiovascular disease before age 50 in male relatives or 
age 60 in female relatives, or a family history suggestive of familial 
hyperlipidemia)  
Hypertension  Screen men and women ≥18 years g  
Abdominal 
aortic aneurysm 
 Screen by ultrasonography men aged 65-75 years of age if they have ever 
smoked  
• Adapted from USPSTF 18  
• g All refugees should have an initial blood pressure checked at the new-arrival medical 
evaluation.  
Through acculturation, refugees may adopt diets and lifestyles that increase their risks of obesity, 
diabetes, and cardiovascular diseases. Because of competing concerns of settling in a new 
country, the new-arrival screening visit is not the ideal setting to discuss regular exercise and 
healthy diets, but the importance of yearly preventive visits should be discussed, and people with 
disease may be identified. Given clinical latitude, for refugees who are especially well adjusted it 
is appropriate to discuss likely future issues such as obesity, diet, and exercise. Translated and 
culturally sensitive education materials should be distributed when available. 
6. Cancer Screening 
Immigrants are less likely than the general U.S. population to receive screening tests for cervical, 
breast and colorectal cancers. 19 Foreign-born populations may be adversely effected due to a 
large health-care disparity in screening for cancers and may experience worse disease outcomes. 
19 Many factors, particularly limited access to care and cultural barriers, account for these 
disparities. Interestingly, socioeconomic factors, including education and income levels, do not 
appear to strongly influence the likelihood that refugees will obtain appropriate screening tests. 19 
Refugees, as with all U.S. populations, should receive preventive screening according to 
USPSTF Cancer Screening Guidelines (Table 4). The new-arrival medical screening 
examination may not be the ideal time to perform invasive medical screening examinations (e.g., 
pelvic examinations), since many refugees have experienced sexual assault or other traumatic 
events. However, if an appropriate environment can be created, trust can be established, cultural 
norms respected, and the risk of additional trauma to the refugee minimized, the visit does 
present a possible opportunity to provide more invasive cancer screening. Even when invasive 
examinations are not possible, measures can be taken during new-arrival screening to promote 
access to future health care and reduce cultural barriers, which may increase cancer screening in 
refugee populations. Such measures include identifying a primary-care provider, explaining the 
importance of annual preventive care visits (promoting the message that medical care is for 
prevention and not just disease), and using professional interpreters to help educate refugees on 
the benefits of preventive screening in a culturally sensitive manner. In addition, behavioral risks 
can be addressed, such as avoiding the use of tobacco, alcohol, and other substances (e.g., khat, 
betel nut) that predispose toward cancer. 
Refugee populations are at a disproportionally increased risk for cancers that occur in the 
developing world, such as cancers of the liver, esophagus, and stomach. 20 21 22 23 There are no 
specific guidelines in the United States. for screening for cancers that occur disproportionally in 
migrants from the developing world, so the clinician must have a low threshold for investigation 
and early identification of cancers that are common in these populations but not encountered 
frequently in the United States. 
Two extremely prevalent predisposing medical conditions, hepatitis B and H. pylori, are noted 
here. Hepatitis B is the leading cause of hepatocarcinoma worldwide. Although screening 
guidelines are under development for hepatocarcinoma in hepatitis B-infected people in the 
United States, they are not published yet. People with known hepatitis B infection should be 
referred for possible treatment. In addition, follow-up should be arranged for infected people to 
be screened on at least a semi-annual basis for early detection of disease by imaging (i.e., right 
upper quadrant ultrasound) and blood tests (alpha-fetoprotein and aspartate aminotransferase).  
Refugees also have extremely high rates of H. pylori infection, which increases risk for gastric 
cancer. 24 Eradication therapy for H. pylori may decrease this risk, especially if administered 
before the appearance of precancerous lesions. However, experts to date have not recommended 
screening asymptomatic people in high-risk populations; thus, clinical judgment must be used 
when working in populations with very high rates of infection and high rates of gastric 
carcinoma. 
Table 4. Summary of USPSTF cancer screening guidelines 18 
Cervical cancer 
 Women should be screened with cervical cytology (Papanicolaou smears) at 
least every 3 years starting at age 21 or within 3 years of onset of sexual 
activity (whichever comes first). 
(Since the sensitivity of a single smear may be 60%-80%, most 
organizations suggest obtaining annual smears until 2 or 3 consecutive 
negative results are obtained before spacing screening to every 3 years.)  
 Screening can be discontinued after age 65 in women with previous 
negative screenings.  
 Screening is not required in women who have had a total hysterectomy for 
benign disease.  
Breast cancer 
Biennial screening mammography should be offered to women aged 50-74 
years of age.  Further recommendations are available from the U.S. 
Preventive Services Task Force (18) 
Colorectal cancer 
 Men and women ≥ 50 years of age should be screened by one of the 
following methods:  
 Fecal occult blood testing of 3 consecutive stools annually  
 Flexible sigmoidoscopy or double-contrast barium enema every 5 years  
 Colonoscopy every 10 years  
 
7. Female Genital Cutting (also known as female circumcision, female genital 
mutilation, and female genital excision) 
Female genital cutting refers to all procedures involving partial or total removal of female 
genitalia or other injury to female genital organs for any cultural, religious or otherwise 
nontherapeutic reasons. This practice is common in many refugee populations, particularly those 
from East Africa (i.e. Somalia, Ethiopia, Sudan), although the practice is pervasive throughout 
the world. This controversial practice is considered a human rights violation by many, and it is 
illegal in the United States in people under 18 years of age. The World Health Organization 
(WHO) has condemned the practice and is making efforts to end it. The practice poses adverse 
medical consequences, including direct complications from the procedure (anesthesia or sedation 
complications, bleeding, acute infection), increased risk of death for both mother and infant in 
subsequent pregnancies, post-traumatic stress disorder, and urinary tract infections, among 
others. In addition, there may be adverse consequences for the woman’s sexual well-being. 
An external genital examination will reveal whether a girl or woman has undergone this 
procedure. Although this examination is required on the overseas medical evaluation, it may not 
have been performed, and the domestic medical screening evaluation presents an opportunity to 
identify women who have had the procedure. The exam may also provide opportunities to 
interrupt the practice in future generations. When the practice is identified, the clinician should 
record what type of procedure was performed (Table 5). Culturally sensitive counseling and 
educational materials should be offered and, when necessary, referrals provided (e.g., for 
complications or posttraumatic stress disorder). The refugee can be informed that the procedure 
is illegal in the United States. 
More detailed information regarding female genital cutting is available from the World Health 
Organization . 
Table 5. World Health Organization Categorization of Female Genital Cutting 
Type I Partial or total removal of the clitoris (clitorectomy). 
Type II Partial or total removal of the clitoris and the labia minora, with or without excision of the labia majora. 
Type III 
Narrowing of the vaginal orifice with creation of a covering seal by cutting and 
appositioning the labia minora and/or majora (infibulation), with or without excision 
of the clitoris. 
Type IV All other harmful procedures to the female genitalia for nonmedical purposes (e.g., piercing, incising, pricking, scraping, and cauterizating) 
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